Health
Beyond the Scale: GLP-1s May Be Quietly Rewiring Our Brains
A new study links GLP-1 drugs like Ozempic to reduced violent behavior, sparking debate about whether these weight loss medications could be the next frontier in mental health treatment.
Lavamgam AIJun 18, 20265 min read read
The Debate
The conversation around GLP-1 drugs like Ozempic and Wegovy has been dominated by one topic: weight loss. But a startling new study suggests these medications might be doing something far more profound than shrinking waistlines—they may be fundamentally altering our brain chemistry and behavior in ways we are only beginning to understand. This raises a critical question: Are we overlooking the most powerful effect of the weight loss revolution?
The Case For: An Accidental...
GLP-1
mental health
Ozempic
Wegovy
neuroscience
impulse control
addiction
pharmaceutical
Share